Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

QMAPP® (Hemo, Hemo Lite, PCM, GO, Hybrid)

K-Number: K241766 · 2025-08-27

ApplicantFysicon BV
Decision Date2025-08-27
Product CodeMWI
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

QMAPP® (Hemo, Hemo Lite, PCM, GO, Hybrid) is a medical device manufactured by Fysicon BV. It received FDA 510(k) clearance on 2025-08-27 under approval number K241766. The device is classified under product code MWI. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the QMAPP® (Hemo, Hemo Lite, PCM, GO, Hybrid)?

QMAPP® (Hemo, Hemo Lite, PCM, GO, Hybrid) is a medical device that received FDA 510(k) clearance on 2025-08-27. It is manufactured by Fysicon BV. The 510(k) number is K241766.

When was QMAPP® (Hemo, Hemo Lite, PCM, GO, Hybrid) approved by the FDA?

QMAPP® (Hemo, Hemo Lite, PCM, GO, Hybrid) received FDA 510(k) clearance on 2025-08-27, under approval number K241766.

What company makes QMAPP® (Hemo, Hemo Lite, PCM, GO, Hybrid)?

QMAPP® (Hemo, Hemo Lite, PCM, GO, Hybrid) is manufactured by Fysicon BV.

What is the FDA product code for QMAPP® (Hemo, Hemo Lite, PCM, GO, Hybrid)?

The FDA product code for QMAPP® (Hemo, Hemo Lite, PCM, GO, Hybrid) is MWI.

Other Devices by Fysicon BV

Related Devices (Code: MWI)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.